SW033291

SW033291

Cat. No.: DIA-0230199

Size: 50 mg Size: 500 mg Size: Customer Size
Product Information
CAS No. 459147-39-8
Formula C21H20N2OS3
Molecular Weight 412.59
SMILES CCCC[S](=O)C1=C(N)C2=C(C=C(N=C2S1)C3=CC=CS3)C4=CC=CC=C4
Target 15-hydroxyprostaglandin dehydrogenase (15-PGDH)
Product Description SW033291 is a selective inhibitor of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) with IC50 and Kiapp of 1.5 nM and 0.1 nM, respectively.
Format & Storage
Purity > 99%
Shipping Shipped on dry ice.
Storage Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month
Solubility Overview Soluble in DMSO
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top